Trials / Conditions / Influenza Vaccines

Influenza Vaccines

30 registered clinical trials studyying Influenza Vaccines — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Vaccination Nudges From Pharmacists NCT07161739	University of Calgary	N/A
Recruiting	Characterizing the Human Airway Immune Response to FluMist Vaccination NCT07177417	Washington University School of Medicine	Phase 4
Recruiting	Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared NCT06676644	National Taiwan University Hospital	N/A
Not Yet Recruiting	Vaccine Chatbot for Improving Influenza Vaccination Uptake NCT06657573	Fudan University	N/A
Unknown	Influenza Vaccine Uptake Among Healthcare Workers NCT05521763	International Centre for Diarrhoeal Disease Research, Bangladesh	N/A
Unknown	Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 NCT05298800	Centers for Disease Control and Prevention, China	Phase 4
Completed	Financing Strategies of Influenza Vaccination in China NCT04038333	Peking University	—
Active Not Recruiting	A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD NCT03734237	Henry M. Jackson Foundation for the Advancement of Military Medicine	Phase 4
Completed	Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children NCT03735147	Imperial College London	Phase 4
Completed	Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado NCT03246100	University of Colorado, Denver	N/A
Completed	Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan NCT03057483	Butantan Institute	—
Completed	Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis NCT02831608	Ole Frobert, MD, PhD	Phase 4
Completed	Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates NCT02761551	University of Colorado, Denver	N/A
Completed	Adjuvanted Influenza Vaccine in Stem Cell Transplant NCT02560909	University Health Network, Toronto	Phase 4
Completed	Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents NCT02358083	Indiana University	N/A
Completed	Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Infl NCT01788228	GlaxoSmithKline	Phase 3
Withdrawn	MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly NCT01623232	US Department of Veterans Affairs	Phase 1 / Phase 2
Completed	Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age NCT01310413	GlaxoSmithKline	Phase 3
Terminated	Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Child NCT01195779	GlaxoSmithKline	Phase 2
Completed	Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly NCT01013675	Abbott Biologicals	Phase 2
Completed	Evaluation of a School-based Influenza Vaccination Program NCT00961337	Centers for Disease Control, Taiwan	Phase 4
Completed	Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years NCT00718120	GlaxoSmithKline	Phase 3
Completed	A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk NCT00586469	GlaxoSmithKline	Phase 4
Completed	Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) NCT00449670	GlaxoSmithKline	Phase 3
Completed	Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK11 NCT00430521	GlaxoSmithKline	Phase 2
Completed	Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy NCT00402805	University Health Network, Toronto	Phase 4
Completed	The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting. NCT00265161	HaEmek Medical Center, Israel	—
Completed	Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population NCT00306995	GlaxoSmithKline	Phase 2
Completed	Memory for Flu Facts and Myths and Effects on Vaccine Intentions NCT00296270	University of Michigan	N/A
Completed	Influenza Vaccination and Oral Anticoagulant Therapy NCT00222638	University Of Perugia	Phase 4